Dynamics of antioxidant defense system indicators in children with osteosarcoma during high-dose chemotherapy with methotrexate
- Authors: Neborak E.V.1, Lebedeva A.V.1, Golovnya E.G.1, Nisichenko D.V.1, Dzampaev A.Z.1, Baykova V.N.1, Aliev M.D.1
-
Affiliations:
- N.N. Blokhin Russian Cancer Research Center, Ministry of Health of Russian Federation
- Issue: Vol 9, No 1 (2017)
- Pages: 3-11
- Section: EDITORIAL
- Published: 16.01.2017
- URL: https://sarbon.abvpress.ru/jour/article/view/336
- ID: 336
Cite item
Full Text
Abstract
One of the factors of Mtx toxicity during high-dose chemotherapy is its prooxidant action. For the compensation of arising oxidative stress such antioxidant drugs as ademetionin are used in clinical. The purpose of the study: investigation of the dynamics of antioxidant defense system indicators in children during high-dose chemotherapy. The object of study: 246 patients who received high-dose Mtx chemotherapy, aged 9–15 years.
Methods. Determination of GGT, GR, SOD and OAOS in blood on key hours from the start of Mtx administration – 4, 24, 42, 48; determination of their biokinetics parameters.
Results. For the first 4 courses the regularities are found: GGT activity and SOD have a maximum increase in the 4th hour, further reduced. SOD activity recovers slightly up to 48th hour. Levels of GR and OAOS are the lowest for the 4th hour, then increased to a level above the reference one.
Conclusion. Oxidative stress caused by the action of Mtx, can be compensated by coadministration of ademetionine, which has a positive effect on all measured indicators. After 4 courses of high-dose Mtx chemotherapy hepatotoxicity increases despite of treatment with ademetionine the degree of hepatotoxicity is growing, which founds the reflection in the dynamics of SOD and GGT.
About the authors
E. V. Neborak
N.N. Blokhin Russian Cancer Research Center, Ministry of Health of Russian Federation
Moscow
Russian FederationA. V. Lebedeva
N.N. Blokhin Russian Cancer Research Center, Ministry of Health of Russian Federation
Moscow
Russian FederationE. G. Golovnya
N.N. Blokhin Russian Cancer Research Center, Ministry of Health of Russian Federation
Moscow
Russian FederationD. V. Nisichenko
N.N. Blokhin Russian Cancer Research Center, Ministry of Health of Russian Federation
Author for correspondence.
Email: nisichenko@gmail.com
Moscow
Russian FederationA. Z. Dzampaev
N.N. Blokhin Russian Cancer Research Center, Ministry of Health of Russian Federation
Moscow
Russian FederationV. N. Baykova
N.N. Blokhin Russian Cancer Research Center, Ministry of Health of Russian Federation
Moscow
Russian FederationM. D. Aliev
N.N. Blokhin Russian Cancer Research Center, Ministry of Health of Russian Federation
Moscow
Russian FederationReferences
Supplementary files


